Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalation Study Evaluating Stereotactic Radiosurgery for Liver Malignancies

NCT00230347 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00230347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00230347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalation Study Evaluating Stereotactic Radiosurgery for Liver Malignancies
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2003
Completion date
February 28, 2007
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, cholangiocarcinoma, liver cancer